Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Outcomes of Reference Pricing for Angiotensin-Converting–Enzyme Inhibitors

4 references·16 citing·46 second hop

FromToDepth

this work references cited by second hop

References

2001Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons873 cited
1999METHODS FOR ANALYZING HEALTH CARE UTILIZATION AND COSTS663 cited
1987Payment Restrictions for Prescription Drugs under Medicaid409 cited
1990The Effect of Drug Co-Payments on Utilization and Cost of Pharmaceuticals in a Health Maintenance Organization188 cited

Cited by

2013The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use159 cited
2003Proposal of the Physicians' Working Group for Single-Payer National Health Insurance143 cited
2004Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid132 cited
2003Reference Pricing For Drugs: Is It Compatible With U.S. Health Care?118 cited
2004Book Review: The Impact of Cost-Sharing on Appropriate Utilization and Health Status: A Review of the Literature on Seniors116 cited
2004Medicaid Prior-Authorization Programs and the Use of Cyclooxygenase-2 Inhibitors111 cited
2010Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?93 cited
2010Effects of Reference Pricing in Pharmaceutical Markets88 cited
2005Effect of Increased Cost-Sharing on Oral Hypoglycemic Use in Five Managed Care Organizations87 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

2009Is There a Relationship Between Patient Beliefs or Communication About Generic Drugs and Medication Utilization?87 cited

2003Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications85 cited

2014Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies84 cited

2002Reference-Based Pricing Schemes77 cited

2003Economic Consequences of Underuse of Generic Drugs: Evidence from Medicaid and Implications for Prescription Drug Benefit Plans72 cited

2004Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations68 cited

2007Patient, Physician, Pharmacy, and Pharmacy Benefit Design Factors Related to Generic Medication Use64 cited